More Business Wire
View Older Stories View Newer Stories-
Light & Wonder Announces Strategic Acquisition of Grover Gaming’s Charitable Gaming Assets
-
Payfinia Partners with TAPP Engine to Provide Instant Wealth Management Capabilities
-
SRA Watchtower Raises $4 Million in New Funding Led by FINTOP Capital, JAM FINTOP, and EJF Capital
-
Cambridge GaN Devices Secures $32M to Drive Global Growth in Power Semiconductor Industry
-
One Equity Partners Agrees to Acquire Wheeler Fleet Solutions
-
DocGo Announces Upcoming Participation at TD Cowen 45th Annual Health Care Conference
-
A.R.I. Partners with Hypereon Labs to Drive AI-Powered Innovation
-
Realbotix Releases Robotic AI Vision System
-
AREP Fund IV Oversubscribed at $309M
-
The AZEK® Company Acquires Northwest Polymers, Expanding Recycling Capabilities in Pacific Northwest
-
Teledyne FLIR’s Black Hornet 4 Nano-Drone Selected as Winner of the Defense Innovation Unit’s Blue UAS Challenge
-
High Side Technology Team Welcomes Andrew Pidduck as CGO/COO
-
Irakli Rukhadze of Imedi Media Holding: Statement concerning the EU Parliament’s resolution on Georgia
-
Offerpad Announces Participation in the Citizens JMP Technology Conference
-
United Rentals, Inc. Will No Longer Pursue the Acquisition of H&E Equipment Services, Inc.
-
ECS President John Heneghan Named a Wash100 2025 Award Winner
-
Accelerate Third-Party Assessments: ProcessUnity Global Risk Exchange Delivers World’s Largest Library of Third-Party Risk Data
-
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
-
Extreme Networks Announces $200 Million Share Repurchase Authorization
-
U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of a Second Patent Asserted by Exact Sciences
-
Asbury Automotive Group Agrees to Acquire The Herb Chambers Companies
-
Herc Holdings Confirms Superior Proposal to Acquire H&E Equipment Services
-
The Art of Taking Action at the Heart of C2MTL’s 14th Edition
-
Nura Bio Expands Leadership Team with C-Suite Appointments
-
Work to rule starts today at Parkland School Division
-
Align Partners with Engineering Services Firm AKS
-
N-able Celebrates Five Years of Empowering Partners with Head Nerds Program
-
Sentinel Midstream’s “Texas Gulflink” Deepwater Port Receives Approval From U.S. Maritime Administration
-
Laser Photonics Expands Into Architectural Market With Cascade Coil Drapery Order
-
Maritime Launch Services Announces Approval of Financing and Two-Year Debenture Extension
-
Origin Materials Announces Fourth Quarter 2024 Earnings Release Date and Conference Call
-
NationsBenefits® Expands Retail Network with Walgreens, Leveraging Innovative Fintech to Improve Member Access to Health and Wellness Products Nationwide
-
XRHealth Acquires Immersive, Digital Therapeutics Company RealizedCare, Creating the Largest AI-Driven Therapeutic XR Platform Globally
-
Sierra Metals Subsidiary in Peru, Sociedad Minera Corona Reports Q4 2024 Financial Results
-
ReposiTrak Adds 50 New Food Suppliers to the Queue for the Rapidly Expanding Food Traceability Network
-
United Natural Foods to Release Fiscal 2025 Second Quarter Results on March 11, 2025
-
VSE Corporation Announces Agreement to Sell Fleet Segment
-
SynergenX Underscores Hormone Testing in Adults as an Essential Step Toward a Healthier New Year
-
D-Wave and Staque Announce New Hybrid-Quantum Application for Optimization of Autonomous Agriculture Vehicle Movements
-
Bowman Expands Oil and Gas Footprint With Acquisition of UP Engineering
-
Join Veritone, IDC and AWS to Uncover Actionable Strategies for Driving AI Success in Upcoming Webinar
-
Foundation Medicine Collaborates with Sumitomo Pharma America to Advance Investigational Treatment for Patients with Acute Leukemia with NPM1 Mutations or KMT2A Rearrangements Using the FoundationOne�
-
Allay Therapeutics Announces First Patients Dosed in Pivotal Phase 2b Registration Trial of ATX101 for Post-Surgical Pain Management After Knee Replacement Surgery
-
Valmont Reports Fourth Quarter and Full-Year 2024 Results
-
Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering
-
Fortune Names Ryder Among World's Most Admired Companies in 2025
-
Constellation Reports Fourth Quarter and Full Year 2024 Results
-
Northern Trust Expands Partnership with Alchemy to Support Its New Special Opportunities Fund
-
Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock
-
Fluor Reports Fourth Quarter and Full Year 2024 Results
